These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32888502)

  • 1. Designed Parasite-Selective Rhomboid Inhibitors Block Invasion and Clear Blood-Stage Malaria.
    Gandhi S; Baker RP; Cho S; Stanchev S; Strisovsky K; Urban S
    Cell Chem Biol; 2020 Nov; 27(11):1410-1424.e6. PubMed ID: 32888502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1.
    Lidumniece E; Withers-Martinez C; Hackett F; Collins CR; Perrin AJ; Koussis K; Bisson C; Blackman MJ; Jirgensons A
    Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33975947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of intramembrane proteases in protozoan parasites.
    Sibley LD
    Biochim Biophys Acta; 2013 Dec; 1828(12):2908-15. PubMed ID: 24099008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct mechanisms govern proteolytic shedding of a key invasion protein in apicomplexan pathogens.
    Howell SA; Hackett F; Jongco AM; Withers-Martinez C; Kim K; Carruthers VB; Blackman MJ
    Mol Microbiol; 2005 Sep; 57(5):1342-56. PubMed ID: 16102004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Plasmodium rhomboid proteases preferentially cleave different adhesins implicated in all invasive stages of malaria.
    Baker RP; Wijetilaka R; Urban S
    PLoS Pathog; 2006 Oct; 2(10):e113. PubMed ID: 17040128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not a Simple Tether: Binding of Toxoplasma gondii AMA1 to RON2 during Invasion Protects AMA1 from Rhomboid-Mediated Cleavage and Leads to Dephosphorylation of Its Cytosolic Tail.
    Krishnamurthy S; Deng B; Del Rio R; Buchholz KR; Treeck M; Urban S; Boothroyd J; Lam YW; Ward GE
    mBio; 2016 Sep; 7(5):. PubMed ID: 27624124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocatalytic activation of a malarial egress protease is druggable and requires a protein cofactor.
    Tan MSY; Koussis K; Withers-Martinez C; Howell SA; Thomas JA; Hackett F; Knuepfer E; Shen M; Hall MD; Snijders AP; Blackman MJ
    EMBO J; 2021 Jun; 40(11):e107226. PubMed ID: 33932049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive targeting of chemical space at the prime side of ketoamide inhibitors of rhomboid proteases by branched substituents empowers their selectivity and potency.
    Bach K; Dohnálek J; Škerlová J; Kuzmík J; Poláchová E; Stanchev S; Majer P; Fanfrlík J; Pecina A; Řezáč J; Lepšík M; Borshchevskiy V; Polovinkin V; Strisovsky K
    Eur J Med Chem; 2024 Sep; 275():116606. PubMed ID: 38901105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Plasmodium falciparum protease inhibitors in the past decade (2002-2012).
    Pérez B; Teixeira C; Gomes JR; Gomes P
    Curr Med Chem; 2013; 20(25):3049-68. PubMed ID: 23514416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of malaria merozoite proteases in red blood cell invasion.
    O'Donnell RA; Blackman MJ
    Curr Opin Microbiol; 2005 Aug; 8(4):422-7. PubMed ID: 16019257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial protease.
    Chance JP; Fejzic H; Hernandez O; Istvan ES; Andaya A; Maslov N; Aispuro R; Crisanto T; Nguyen H; Vidal B; Serrano W; Kuwahara B; Pugne Andanado C; Goldberg DE; Mallari JP
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1846-1848. PubMed ID: 29691139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole-based non-peptidomimetic plasmepsin inhibitors.
    Kinena L; Leitis G; Kanepe-Lapsa I; Bobrovs R; Jaudzems K; Ozola V; Suna E; Jirgensons A
    Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800151. PubMed ID: 30063266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library.
    Carroll CD; Patel H; Johnson TO; Guo T; Orlowski M; He ZM; Cavallaro CL; Guo J; Oksman A; Gluzman IY; Connelly J; Chelsky D; Goldberg DE; Dolle RE
    Bioorg Med Chem Lett; 1998 Sep; 8(17):2315-20. PubMed ID: 9873534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum.
    Arastu-Kapur S; Ponder EL; Fonović UP; Yeoh S; Yuan F; Fonović M; Grainger M; Phillips CI; Powers JC; Bogyo M
    Nat Chem Biol; 2008 Mar; 4(3):203-13. PubMed ID: 18246061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Entamoeba histolytica rhomboid protease with atypical specificity cleaves a surface lectin involved in phagocytosis and immune evasion.
    Baxt LA; Baker RP; Singh U; Urban S
    Genes Dev; 2008 Jun; 22(12):1636-46. PubMed ID: 18559479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Click Inspired Synthesis of Novel Cinchonidine Glycoconjugates as Promising Plasmepsin Inhibitors.
    Mishra N; Agrahari AK; Bose P; Singh SK; Singh AS; Tiwari VK
    Sci Rep; 2020 Feb; 10(1):3586. PubMed ID: 32108142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
    Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I
    PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General and Modular Strategy for Designing Potent, Selective, and Pharmacologically Compliant Inhibitors of Rhomboid Proteases.
    Tichá A; Stanchev S; Vinothkumar KR; Mikles DC; Pachl P; Began J; Škerle J; Švehlová K; Nguyen MTN; Verhelst SHL; Johnson DC; Bachovchin DA; Lepšík M; Majer P; Strisovsky K
    Cell Chem Biol; 2017 Dec; 24(12):1523-1536.e4. PubMed ID: 29107700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidic Boronic Acid
    Withers-Martinez C; Lidumniece E; Hackett F; Collins CR; Taha Z; Blackman MJ; Jirgensons A
    J Med Chem; 2024 Aug; 67(15):13033-13055. PubMed ID: 39051854
    [No Abstract]   [Full Text] [Related]  

  • 20. Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target.
    Singh J; Vijay S; Mansuri R; Rawal R; Kadian K; Sahoo GC; Kumar M; Sharma A
    PLoS One; 2019; 14(8):e0221032. PubMed ID: 31437171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.